![]() |
市場調查報告書
商品編碼
1930105
全球微創手術器材市場:市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的考量因素以及未來預測(2026-2034)Minimally Invasive Surgery Devices Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
由於對微創手術的需求不斷增長以及持續的技術創新,全球微創手術 (MIS) 器械市場正經歷強勁增長。根據 Fortune Business Insights 預測,該市場規模預計將在 2025 年達到 202.7 億美元,在 2026 年達到 216.1 億美元。到 2034 年,該市場預計將達到 414.1 億美元,在預測期(2026-2034 年)內,複合年增長率 (CAGR) 為 8.47%。北美地區憑藉先進的醫療基礎設施、龐大的手術量和有利的報銷政策,將在2025年佔市場主導地位,市場佔有率高達43.18%。
市場概覽
微創手術器械是專門用於透過微小切口或自然腔道進行手術的醫療設備。這些器械包括內視鏡器械、腹腔鏡器械、機器人輔助系統、導引裝置、擴張裝置以及導航和視覺化系統。與傳統開放式手術相比,微創手術具有顯著優勢,包括減少出血量、最大限度減少疤痕、降低感染風險、縮短住院時間、加速患者復原。
病患和醫療服務提供者對微創手術方式的偏好日益增強,推動了微創手術在包括骨科、心臟科、婦科、胃腸科和神經科在內的多個外科專科領域的廣泛應用。
市場驅動因素
心血管疾病、癌症、糖尿病和肥胖等慢性疾病發生率的上升是市場成長的主要驅動因素。根據2025年1月發布的數據,全球約有6.2億人患有心臟和循環系統疾病,其中許多患者需要手術治療。微創手術因其能夠減少術後併發症並改善臨床療效而日益受到青睞。
此外,骨科和運動相關傷害數量的增加也促進了關節鏡和微創骨科手術的廣泛應用。截至2025年,全球每年將進行超過400萬例膝關節鏡手術,將顯著推動對微創手術(MIS)設備的需求。
市場限制因子
儘管市場成長前景廣闊,但微創手術設備的高昂成本仍是一個主要限制因素。機器人手術系統等先進技術需要大量的初始投資,每個系統的成本超過 200 萬美元,還不包括維護和培訓費用。如此高昂的成本限制了這些技術的應用,使其僅限於資金雄厚的大型醫院,從而阻礙了農村和資源匱乏的醫療機構的廣泛應用。
市場機會
門診手術中心 (ASC) 的快速擴張帶來了巨大的成長機會。根據門診手術中心協會 (ASCA) 統計,到 2024 年,美國將有超過 6,300 家獲得聯邦醫療保險 (Medicare) 認證的門診手術中心投入運作。由於微創技術符合門診護理模式、具成本效益且報銷機制有利,門診手術中心擴大採用微創技術。預計這種轉變將維持對微創手術 (MIS) 設備的長期需求。
市場挑戰
市場面臨的主要挑戰之一是精通微創技術的醫生短缺。根據美國醫學院協會的數據,到 2036 年,美國可能面臨高達 30,200 名外科醫生的缺口。專業培訓機會有限,尤其是在發展中地區,阻礙了微創手術 (MIS) 技術和設備的廣泛應用。
市場趨勢
持續的技術創新正在重塑微創手術領域。機器人輔助手術系統、人工智慧導航工具、3D 影像和微型化器械正在提高手術精度和效果。單孔腹腔鏡手術和自然切口手術因其減少疤痕和加快恢復速度而日益普及,進一步推動了對先進微創手術設備的需求。
區域分析
預計北美市場在2025年將達到87.5億美元,其中美國市場預計到2026年將達到88.1億美元。
由於機器人手術的普及,歐洲市場持續做出重大貢獻,預計德國市場到2026年將達到13.5億美元。
受人口老化和醫療保健投資增加的推動,亞太地區預計將實現最快的成長速度。預計到 2026 年,中國將達到 17.9 億美元,日本將達到 13.8 億美元,印度將達到 3.7 億美元。
The global minimally invasive surgery (MIS) devices market is experiencing robust growth due to the rising preference for less traumatic surgical procedures and continuous technological advancements. According to Fortune Business Insights, the market was valued at USD 20.27 billion in 2025 and is projected to grow to USD 21.61 billion in 2026. By 2034, the market is expected to reach USD 41.41 billion, registering a CAGR of 8.47% during the forecast period (2026-2034). North America dominated the market in 2025 with a share of 43.18%, supported by advanced healthcare infrastructure, high surgical volumes, and favorable reimbursement policies.
Market Overview
Minimally invasive surgery devices are specialized medical instruments used to perform surgical procedures through small incisions or natural body openings. These devices include endoscopic devices, laparoscopic instruments, robotic-assisted systems, guiding devices, inflation devices, and navigation & visualization systems. MIS procedures offer significant advantages over traditional open surgeries, including reduced blood loss, minimal scarring, lower infection risk, shorter hospital stays, and faster patient recovery.
The growing preference for minimally invasive approaches among both patients and healthcare providers is driving widespread adoption across multiple surgical disciplines, including orthopedics, cardiology, gynecology, gastrointestinal surgery, and neurology.
Market Drivers
The rising incidence of chronic diseases such as cardiovascular disorders, cancer, diabetes, and obesity is a major factor driving market growth. According to data published in January 2025, nearly 620 million people worldwide live with heart and circulatory diseases, many of whom require surgical intervention. Minimally invasive procedures are increasingly favored due to their ability to reduce postoperative complications and improve clinical outcomes.
Additionally, the increasing number of orthopedic and sports-related injuries is contributing to higher adoption of arthroscopic and minimally invasive orthopedic surgeries. As of 2025, over 4 million arthroscopic knee surgeries are performed annually worldwide, significantly boosting demand for MIS devices.
Market Restraints
Despite strong growth prospects, high costs associated with MIS devices remain a key restraint. Advanced technologies such as robotic surgical systems require substantial upfront investment, often exceeding USD 2.0 million per system, excluding maintenance and training costs. These high expenses limit adoption to large, well-funded hospitals and restrict penetration in rural and resource-limited healthcare settings.
Market Opportunities
The rapid expansion of ambulatory surgery centers (ASCs) presents a major growth opportunity. According to the Ambulatory Surgery Centers Association, over 6,300 Medicare-certified ASCs were operational in the U.S. as of 2024. ASCs increasingly adopt minimally invasive technologies due to their alignment with outpatient care models, cost efficiency, and favorable reimbursement structures. This shift is expected to sustain long-term demand for MIS devices.
Market Challenges
A significant challenge facing the market is the shortage of skilled surgical professionals trained in minimally invasive techniques. According to the American Association of Medical Colleges, the U.S. may face a shortage of up to 30,200 surgeons by 2036. Limited access to specialized training, particularly in developing regions, hampers the widespread adoption of MIS procedures and devices.
Market Trends
Continuous technological advancements are reshaping the MIS landscape. Robotic-assisted surgical systems, AI-powered navigation tools, 3D imaging, and miniaturized instruments are enhancing surgical precision and outcomes. Single-port laparoscopic and natural orifice surgeries are gaining popularity due to reduced scarring and faster recovery, further fueling demand for advanced MIS devices.
Regional Analysis
North America accounted for USD 8.75 billion in 2025, with the U.S. market expected to reach USD 8.81 billion by 2026.
Europe remains a strong contributor, supported by robotic surgery adoption, with Germany projected to reach USD 1.35 billion by 2026.
Asia Pacific is expected to grow at the fastest rate, driven by aging populations and rising healthcare investments. By 2026, China is projected at USD 1.79 billion, Japan at USD 1.38 billion, and India at USD 0.37 billion.
Competitive Landscape
The market is consolidated, with key players such as Medtronic, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Boston Scientific, Olympus, Stryker, B. Braun, and Intuitive Surgical. These companies focus on product innovation, strategic collaborations, and geographic expansion to strengthen their market presence.
Conclusion
The global minimally invasive surgery devices market is poised for strong expansion, growing from USD 20.27 billion in 2025 to USD 41.41 billion by 2034. Increasing prevalence of chronic diseases, rising adoption of outpatient surgical procedures, and continuous technological innovation are driving market growth. While high costs and workforce shortages remain challenges, expanding ambulatory care infrastructure and advancements in robotic and AI-assisted technologies are expected to shape the future of minimally invasive surgery worldwide.
Segmentation By Type
By Application
By End-user
By Geography